about
Oxidative Stress in Neurodegenerative DiseasesGenetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies.Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke.Genetic variants in CETP increase risk of intracerebral hemorrhage.Pathogenic ischemic stroke phenotypes in the NINDS-stroke genetics networkGenome-wide association study of intracranial aneurysm identifies a new association on chromosome 7.Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study.Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhageHeritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhageBurden of risk alleles for hypertension increases risk of intracerebral hemorrhage.APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study.The sustained increase of plasma fibrinogen during ischemic stroke predicts worse outcome independently of baseline fibrinogen levelHyperfibrinogenemia predicts long-term risk of death after ischemic stroke.PRospective Observational POLIsh Study on post-stroke delirium (PROPOLIS): methodology of hospital-based cohort study on delirium prevalence, predictors and diagnostic tools.Glutamate transporters in brain ischemia: to modulate or not?N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression.Improvement of survival in Polish stroke patients is related to reduced stroke severity and better control of risk factors: the Krakow Stroke Database.Gene expression profiling of blood in ruptured intracranial aneurysms: in search of biomarkersInfluence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with alzheimer's disease.Shared Genetic Risk Factors of Intracranial, Abdominal, and Thoracic AneurysmsOxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain.Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism.Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflammation?The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.Biochemical and Radiological Markers of Alzheimer's Disease Progression.Association between C677T polymorphism of MTHFR gene and risk of amyotrophic lateral sclerosis: Polish population study and a meta-analysis.Can Prediction of Functional Outcome after Stroke Be Improved by Adding Fibrinogen to Prognostic Model?II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm.Alpha1-antichymotrypsin gene (SERPINA3) A/T polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage.Stroke attack rates and case fatality in the Krakow Stroke Registry.Pre-stroke apathy symptoms are associated with an increased risk of delirium in stroke patients.Decompensated Heart Failure Is a Strong Independent Predictor of Functional Outcome After Ischemic Stroke.PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients.Ceftriaxone- and N-acetylcysteine-induced brain tolerance to ischemia: Influence on glutamate levels in focal cerebral ischemia.Interleukin 1beta-511 C/T polymorphism and risk of aneurysmal subarachnoid haemorrhageLack of association between interleukin-1 beta polymorphism (-511) and ischaemic stroke.The impact of postadmission glycemia on stroke outcome: Glucose normalisation is associated with better survival.Temporal changes of adiponectin plasma levels in patients with acute ischemic stroke.Interobserver agreement in perfusion computed tomography evaluation in acute ischaemic stroke.Transient hyperglycemia in ischemic stroke patients.
P50
Q26801239-4A1A3D05-21C7-4A8F-976F-EB9D8B3F76D2Q29417025-4484666E-7283-4B62-9F33-84E7260B7C15Q29417129-EA1524CB-EF4A-43FF-9167-D292F122031FQ30275688-2E523F71-9234-4344-B0FF-9BEEE03691F1Q30301308-C65608F7-37B1-4719-9A71-BC828F82942CQ30370233-6B242034-B100-4940-9C90-54163A8C3E9EQ30405640-EBDD9A68-37EF-46FE-834B-9C76707983B4Q30410308-78F74E60-E1F4-4BE3-9436-C2F1BE61E31CQ30412882-FC87BA58-B857-4876-BB76-7F80BAB403F4Q30416687-741DF2C6-CFA3-4F17-AE0A-47F0A7A600CEQ30425779-6AC06866-95B4-4838-A769-295ECB18D002Q33829326-7F64551C-600F-4E8C-BE20-BCDC1C8A9D04Q34277735-19918BF8-D9E1-42FD-8986-7C9F5DB4C285Q35755521-C647677A-529F-48FC-9E3D-444E4DF0297AQ36745208-C25B9F4F-9A6E-41D0-ABFF-B923335FDBA0Q36764301-F435EE68-4AB1-4250-B88B-B6E06D672812Q36958277-C753FA58-E2C3-401F-BCF2-726DAD1AA8FAQ36994302-DA9E9A2E-99EB-42C5-935A-E4A6DE86917AQ37092283-AD894320-2DDB-4836-B469-6CEE9BD2762BQ37240605-39A6DCA3-4C4A-4A21-87DD-6FAE7658B0ECQ38453978-ACC7BB1A-A1F6-4E3C-911A-F6080B2A3B73Q38453984-2AE2ECD3-55CC-4DB0-A890-8E89A53EC7DBQ38507815-A15E8D74-BAED-4473-90B0-2FC2978729BCQ38683919-8D4FC068-F1E1-49D5-A863-1DB8C343FE91Q38693438-6BEA7EAF-A3EC-4E4A-BEEE-DDF3AFFFCAA2Q38966776-E67CD0EC-F31E-4248-9B28-9E4BEE18E6A1Q39510196-F742FC42-A4B8-47BB-B3EF-00F209198CFEQ39686013-0887B986-CCB8-4EE2-A497-D6CD01F2164EQ39708092-E273A5F4-147F-42C4-992A-0233C1502826Q39813738-CBC4D5A8-7469-48ED-B8E3-2A4012BD38F5Q40099601-9291F9E4-935F-4CAF-B282-11D69B866218Q40164060-CA8ACB9C-E4BD-4DDE-99E7-DB0C7E4F835EQ40701122-707AB854-9D14-42A8-AC28-748741666E03Q42680381-9758D22E-9168-48CB-B927-40E4FFD16AEDQ42718511-8104464D-F8A1-4126-93D6-FE9997B400A5Q43044879-C8328816-9945-456C-963E-0BA01DD26FDBQ43123364-46EEE421-79CA-4180-AC5C-4021AE02F515Q43432541-41FABE53-B80D-449E-A5B3-BB4431032776Q43605604-8AD3052F-82FC-4C45-8B49-0FBF9F8B54BEQ43727686-2532DD6C-93D1-4E68-85D3-1B7F928B0C5B
P50
description
Pools onderzoekster
@nl
researcher, ORCID id # 0000-0001-6142-2969
@en
name
Joanna Pera
@ast
Joanna Pera
@ca
Joanna Pera
@cs
Joanna Pera
@en
Joanna Pera
@es
Joanna Pera
@ga
Joanna Pera
@gl
Joanna Pera
@hr
Joanna Pera
@hsb
Joanna Pera
@it
type
label
Joanna Pera
@ast
Joanna Pera
@ca
Joanna Pera
@cs
Joanna Pera
@en
Joanna Pera
@es
Joanna Pera
@ga
Joanna Pera
@gl
Joanna Pera
@hr
Joanna Pera
@hsb
Joanna Pera
@it
prefLabel
Joanna Pera
@ast
Joanna Pera
@ca
Joanna Pera
@cs
Joanna Pera
@en
Joanna Pera
@es
Joanna Pera
@ga
Joanna Pera
@gl
Joanna Pera
@hr
Joanna Pera
@hsb
Joanna Pera
@it
P214
P1053
U-5552-2018
P106
P1153
7007148332
P1412
P1559
Joanna Pera
@pl
P21
P214
P27
P31
P496
0000-0001-6142-2969
P735
P7859
viaf-309874163